Michael A. Walsh, Partner, Strasburger & Price, LLP to Speak at KCs Event on Understanding FDA Guidance on DTC
Summary
The firm represents international, national and middle market Texas-based companies with the goal of finding effective business solutions while complying with the highest standards of character, professionalism and understanding.Pharmaceutical companies and ad sponsors should have a complete understanding of FDA’s current thinking as reflected in this draft guidance to assess its potential impact on their business relations.The Knowledge Group is assembling a panel of distinguished professionals and key regulators to help understand the complex issues related to the draft guidance and its impact on your firm and the broader market.The firm represents international, national and middle market Texas-based companies with the goal of finding effective business solutions while complying with the highest standards of character, professionalism and understanding.To learn more Strasburgers rich history, diverse areas of practice and experienced attorneys, visit www.strasburger.com.Event Synopsis:The Food and Drug Administration recently issued draft guidance to explain its approach to pre-dissemination review of direct-to-consumer (DTC) television advertisements.